The European Mechanical Circulatory Support Summit is one of the world's largest medical congresses in heart pumps. This year, Realheart's CEO Azad Najar was invited to talk about the company's artificial heart and the research that is being conducted.
The European Mechanical Circulatory Support Summit brings together the world elite in heart pump surgery, both industry representatives and researchers. This fifteenth congress took place digitally during five days from 30 November to 4 December.
Azad Najar, CEO of Realheart, was contacted by the Congress' Scientific Committee with an invitation to be one of the speakers. Among other things, Azad talked about the intelligence in Realheart TAH's automatic regulation, which is a prerequisite for increasing patient friendliness and reducing the risk of complications.
For more information please contact:
Azad Najar, CEO
Phone: +46(0)736 673 463
Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart TAH has a unique, patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atriums and two chambers) which provides the opportunity to generate a physiologically adapted blood flow that mimics the body's natural circulation. A unique concept in the medical technology world.